The document discusses confidentiality and protected health information (PHI) under HIPAA. It provides an overview of HIPAA regulations, what should be covered in training, and consequences for non-compliance. HIPAA provides federal privacy protections for PHI held by covered entities like health care providers and insurance companies. Training should cover security breaches, compliance policies, and procedures for handling breached PHI. PHI includes any past, present, or future health information that can identify a person such as names, addresses, or medical records. Assessments with an 80% passing grade are used to issue completion certificates.
Better known as the Health Insurance Portability and Accountability Act, HIPPA law has been initiated to achieve consumer protection in 1996. HIPPA protects customers from theft, financial scams, fake transactions, and also prevents exploitation or injustice done to customers while they are opting for healthcare facilities or for certain policies.
Better known as the Health Insurance Portability and Accountability Act, HIPPA law has been initiated to achieve consumer protection in 1996. HIPPA protects customers from theft, financial scams, fake transactions, and also prevents exploitation or injustice done to customers while they are opting for healthcare facilities or for certain policies.
This slideshow was made based off of an article that we had to read for a Health Care Administration Capstone class. We were to discuss how we, as managers, would implement HIPAA trainings to employees to avoid breaches.
This presentation focuses on the HIPAA law. The presentation covers the definition of HIPAA and what organizations can do to increase and maintain legal compliance.
This slideshow was made based off of an article that we had to read for a Health Care Administration Capstone class. We were to discuss how we, as managers, would implement HIPAA trainings to employees to avoid breaches.
This presentation focuses on the HIPAA law. The presentation covers the definition of HIPAA and what organizations can do to increase and maintain legal compliance.
The American Recovery and Reinvestment Act of 2009 (Stimulus Package) changes made to HIPAA Privacy and Security rules. Congress passed the Act of 17 February 2009.
Overview of hipaa & tools for hipaa complianceSquare 9
http://www.square-9.com/document-management-software | Square 9’s SmartSearch document management system makes it easy to organize and protect confidential patient information and maintain HIPAA compliance. SmartSearch is enterprise-class software that eliminates paper in organizations of all sizes.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
2. Table of contents:
HIPAA
Training sources
What should be covered
Protected Heath Information
Covered Entities
Assessments
3. HIPAA Health Information and
portability Accountability Act The HIPAA Privacy Rule provides federal protections for individually identifiable health
information held by covered entities and their business associates and gives patients an
array of rights with respect to that information (HHS.org).
IN 1996 then President Bill Clinton signed in to law this policy due t the leaking of his own
medical records.
Stae Laws fall behind HIPAA privacy and security regulatons.
.
4. Sources of training
Web Based programs through employers
Online courses
Educational facility lectures
Written manuals
5. What should be covered?
Yearly Training
Security Breach A data breach is a security incident in which sensitive,
protected or confidential data is copied, transmitted, viewed, stolen or
used by an individual unauthorized to do so."
Compliance
policies and regulation
Procedures following a security breach
6. Protected Health Information
Any electronic, paper or oral information from a persons past, present and
future.
Name, Address, social security number
Anything Medical record , hospital stays medical conditions and exams
Acceptable use of PHI.
7. Covered Entities
Health care providers
Social service employee
Health insurance companies
Some business associates
Any staff member that can come across
PHI even janitors
8. Non Compliance penalties and fines
Non compliance fees start at $100.00/
offense with a maximum of $25,000/
year.
Fines will be doubled if privacy rules are
knowingly violated.
Continued violation fee can reach
$250,000 and imprisonment.
9. Assessments
Quizzes will be give at the end to course giving with the passing grade of
80% a certificate of completion.
10. References:
Department of Health and Human Services (nd). Health Information
Privacy. Retrieved from www.hhs.org
